179 related articles for article (PubMed ID: 17437513)
1. Menopausal hormone therapy and gallbladder disease: the Study of Health in Pomerania (SHIP).
Schwarz S; Völzke H; Baumeister SE; Hampe J; Dören M
Clin Endocrinol (Oxf); 2007 Jul; 67(1):51-9. PubMed ID: 17437513
[TBL] [Abstract][Full Text] [Related]
2. Menopause and determinants of quality of life in women at midlife and beyond: the study of health in pomerania (SHIP).
Schwarz S; Völzke H; Alte D; Schwahn C; Grabe HJ; Hoffmann W; John U; Dören M
Menopause; 2007; 14(1):123-34. PubMed ID: 17019378
[TBL] [Abstract][Full Text] [Related]
3. Gynaecological health care utilization and use of sex hormones--the study of Health in Pomerania.
Schwarz S; Völzke H; Alte D; Hoffmann W; John U; Dören M
Hum Reprod; 2005 Oct; 20(10):2916-22. PubMed ID: 15980010
[TBL] [Abstract][Full Text] [Related]
4. Known risk factors do not explain disparities in gallstone prevalence between Denmark and northeast Germany.
Friedrich N; Völzke H; Hampe J; Lerch MM; Jørgensen T
Am J Gastroenterol; 2009 Jan; 104(1):89-95. PubMed ID: 19098855
[TBL] [Abstract][Full Text] [Related]
5. Menopausal hormone therapy and risk of breast cancer: a meta-analysis of epidemiological studies and randomized controlled trials.
Greiser CM; Greiser EM; Dören M
Hum Reprod Update; 2005; 11(6):561-73. PubMed ID: 16150812
[TBL] [Abstract][Full Text] [Related]
6. Should transdermal rather than oral estrogens be used in menopausal hormone therapy? A review.
Fournier A
Menopause Int; 2010 Mar; 16(1):23-32. PubMed ID: 20424283
[TBL] [Abstract][Full Text] [Related]
7. Can menopausal hormone therapy prevent coronary heart disease?
Brinton EA; Hodis HN; Merriam GR; Harman SM; Naftolin F
Trends Endocrinol Metab; 2008 Aug; 19(6):206-12. PubMed ID: 18450469
[TBL] [Abstract][Full Text] [Related]
8. Influence of reproductive history and exogenous hormone use on prevalence and frequency of circulating t(14;18)-positive cells in a population-based cross-sectional study.
Weitmann K; Hirt C; Schwarz S; Rabkin C; Dölken G; Hoffmann W
Cancer Causes Control; 2015 Mar; 26(3):455-65. PubMed ID: 25634026
[TBL] [Abstract][Full Text] [Related]
9. Menopausal hormone therapy in Germany. Results of three national surveys from 1997 to 2003.
Heier M; Moebus S; Meisinger C; Jöckel KH; Völzke H; Döring A; Alte D
Maturitas; 2009 Jan; 62(1):9-15. PubMed ID: 19028032
[TBL] [Abstract][Full Text] [Related]
10. Use of hormone replacement therapy in Italian women aged 50-70 years.
Manzoli L; Di Giovanni P; Del Duca L; De Aloysio D; Festi D; Capodicasa S; Monastra G; Romano F; Staniscia T
Maturitas; 2004 Nov; 49(3):241-51. PubMed ID: 15488353
[TBL] [Abstract][Full Text] [Related]
11. Menopausal hormone therapy and biliary tract cancer: a population-based matched cohort study in Sweden.
Kilander C; Lagergren J; Konings P; Sadr-Azodi O; Brusselaers N
Acta Oncol; 2019 Mar; 58(3):290-295. PubMed ID: 30656997
[TBL] [Abstract][Full Text] [Related]
12. Association between sociodemographic, behavioral, and medical conditions and signs of temporomandibular disorders across gender: results of the study of health in Pomerania (SHIP-0).
Mundt T; Mack F; Schwahn C; Bernhardt O; Kocher T; Biffar R
Int J Prosthodont; 2008; 21(2):141-8. PubMed ID: 18546769
[TBL] [Abstract][Full Text] [Related]
13. Hormone replacement therapy and WONCA/COOP functional status: a cross-sectional population-based study of women in Israel.
Cohen O; Vinker S; Yaphe J; Kitai E
Climacteric; 2005 Jun; 8(2):171-6. PubMed ID: 16096173
[TBL] [Abstract][Full Text] [Related]
14. Study of Health in Pomerania (SHIP): a health survey in an East German region. Objectives and design of the oral health section.
Hensel E; Gesch D; Biffar R; Bernhardt O; Kocher T; Splieth C; Born G; John U
Quintessence Int; 2003 May; 34(5):370-8. PubMed ID: 12795357
[TBL] [Abstract][Full Text] [Related]
15. Association with menopausal hormone therapy and asymptomatic gallstones in US women in the third National Health and Nutrition Examination Study.
Jackson SS; Graubard BI; Gabbi C; Koshiol J
Sci Rep; 2024 Jan; 14(1):191. PubMed ID: 38168135
[TBL] [Abstract][Full Text] [Related]
16. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women.
Schwartz AG; Wenzlaff AS; Prysak GM; Murphy V; Cote ML; Brooks SC; Skafar DF; Lonardo F
J Clin Oncol; 2007 Dec; 25(36):5785-92. PubMed ID: 18089876
[TBL] [Abstract][Full Text] [Related]
17. Past oral contraceptive and hormone therapy use and endogenous hormone concentrations in postmenopausal women.
Chan MF; Dowsett M; Folkerd E; Wareham N; Luben R; Welch A; Bingham S; Khaw KT
Menopause; 2008; 15(2):332-9. PubMed ID: 17667152
[TBL] [Abstract][Full Text] [Related]
18. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
[TBL] [Abstract][Full Text] [Related]
19. No evidence for variation in colorectal cancer risk associated with different types of postmenopausal hormone therapy.
Hoffmeister M; Raum E; Krtschil A; Chang-Claude J; Brenner H
Clin Pharmacol Ther; 2009 Oct; 86(4):416-24. PubMed ID: 19606090
[TBL] [Abstract][Full Text] [Related]
20. Postmenopausal hormone therapy and the risk of cardiovascular disease.
Stramba-Badiale M
J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
